Pathophysiological Association of Alzheimer’s Disease and Hypertension: A Clinical Concern for Elderly Population

References

• Association A. Alzheimer’s disease facts and figures. Alzheimers Dement. 2019;15(3):321–387.
   Web of Science ®Google Scholar
• Gustavsson A, Norton N, Fast T, et al. Global estimates on the number of persons across the Alzheimer’s disease continuum. Alzheimers Dement. 2023;19(2):658–670. doi:10.1002/alz.12694
   PubMed Web of Science ®Google Scholar
• Wong W. Economic burden of Alzheimer disease and managed care considerations. Am J Manag Care. 2020;26(8 Suppl):S177–S183.
   PubMedGoogle Scholar
• Vaz M, Silvestre S. Alzheimer’s disease: recent treatment strategies. Eur J Pharmacol. 2020;887:173554. doi:10.1016/j.ejphar.2020.173554
   PubMed Web of Science ®Google Scholar
• Stephan BC, Pakpahan E, Siervo M, et al. Prediction of dementia risk in low-income and middle-income countries (the 10/66 Study): an independent external validation of existing models. Lancet Global Health. 2020;8(4):e524–e535. doi:10.1016/S2214-109X(20)30062-0
   PubMed Web of Science ®Google Scholar
• Ju Y, Tam KY. Pathological mechanisms and therapeutic strategies for Alzheimer’s disease. Neural Regener Res. 2022;17(3):543. doi:10.4103/1673-5374.320970
   PubMed Web of Science ®Google Scholar
• Silva MVF, Loures CDMG, Alves LCV, et al. Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci. 2019;26(1):1–11. doi:10.1186/s12929-019-0524-y
   PubMedGoogle Scholar
• Zhang -X-X, Tian Y, Wang Z-T, et al. The epidemiology of Alzheimer’s disease modifiable risk factors and prevention. J Prevent Alzheimer’s Dis. 2021;8:313–321. doi:10.14283/jpad.2021.15
   PubMed Web of Science ®Google Scholar
• Lennon MJ, Makkar SR, Crawford JD, et al. Midlife hypertension and Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimer’s Dis. 2019;71(1):307–316. doi:10.3233/JAD-190474
   PubMed Web of Science ®Google Scholar
• Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–2734.
   PubMed Web of Science ®Google Scholar
• Baranowski BJ, Marko DM, Fenech RK, et al. Healthy brain, healthy life: a review of diet and exercise interventions to promote brain health and reduce Alzheimer’s disease risk. Appl Physiol Nutr Metabol. 2020;45(10):1055–1065. doi:10.1139/apnm-2019-0910
   PubMed Web of Science ®Google Scholar
• Sagud M, Tudor L, Pivac N. Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease. Expert Rev Neurother. 2021;21(5):571–589. doi:10.1080/14737175.2021.1906223
   PubMed Web of Science ®Google Scholar
• Cordone S, Scarpelli S, Alfonsi V, et al. Sleep-based interventions in Alzheimer’s disease: promising approaches from prevention to treatment along the disease trajectory. Pharmaceuticals. 2021;14(4):383. doi:10.3390/ph14040383
   Web of Science ®Google Scholar
• Lennon MJ, Koncz R, Sachdev PS. Hypertension and Alzheimer’s disease: is the picture any clearer? Curr Opin Psychiatry. 2021;34(2):142–148. doi:10.1097/YCO.0000000000000684
   PubMed Web of Science ®Google Scholar
• Nyúl-Tóth Á, Tarantini S, Kiss T, et al. Increases in hypertension-induced cerebral microhemorrhages exacerbate gait dysfunction in a mouse model of Alzheimer’s disease. Geroscience. 2020;42(6):1685–1698. doi:10.1007/s11357-020-00256-3
   PubMed Web of Science ®Google Scholar
• de Oliveira LDSSCB, Souza EC, Rodrigues RAS, et al. The effects of physical activity on anxiety, depression, and quality of life in elderly people living in the community. Trends Psychiatry Psychother. 2019;41(p):36–42. doi:10.1590/2237-6089-2017-0129
   PubMedGoogle Scholar
• Diao D, Diao F, Xiao B, et al. Bayes conditional probability-based causation analysis between gestational diabetes mellitus (gdm) and pregnancy-induced hypertension (PIH): a statistic case study in Harbin, China. J Diabetes Res. 2022;2022. doi:10.1155/2022/2590415
   Web of Science ®Google Scholar
• Pan Z-Y, Zhong HJ, Huang DN, Wu LH, He XX. Beneficial effects of repeated washed microbiota transplantation in children with autism. Front Pediatr. 2022;971. doi:10.3389/fped.2022.928785
   Web of Science ®Google Scholar
• Martins G, Corrêa L, Caparrol AJDS, et al. Sociodemographic and health characteristics of formal and informal caregivers of elderly people with Alzheimer’s Disease. Escola Anna Nery. 2019;23(2). doi:10.1590/2177-9465-ean-2018-0327
   Google Scholar
• Wang H, Wang K, Xue Q, et al. Transcranial alternating current stimulation for treating depression: a randomized controlled trial. Brain. 2022;145(1):83–91. doi:10.1093/brain/awab252
   PubMed Web of Science ®Google Scholar
• Dafsari FS, Jessen F. Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease. Transl Psychiatry. 2020;10(1):160. doi:10.1038/s41398-020-0839-1
   PubMed Web of Science ®Google Scholar
• Jeon SY, Byun MS, Yi D, et al. Influence of hypertension on brain amyloid deposition and Alzheimer’s disease signature neurodegeneration. Neurobiol Aging. 2019;75:62–70. doi:10.1016/j.neurobiolaging.2018.11.001
   PubMed Web of Science ®Google Scholar
• Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease. Lancet. 2021;397(10284):1577–1590. doi:10.1016/S0140-6736(20)32205-4
   PubMed Web of Science ®Google Scholar
• Matej R, Tesar A, Rusina R. Alzheimer’s disease and other neurodegenerative dementias in comorbidity: a clinical and neuropathological overview. Clin Biochem. 2019;73:26–31. doi:10.1016/j.clinbiochem.2019.08.005
   PubMed Web of Science ®Google Scholar
• Porsteinsson A, Isaacson RS, Knox S, et al. Diagnosis of early Alzheimer’s disease: clinical practice in 2021. J Prevent Alzheimer’s Dis. 2021;8:371–386. doi:10.14283/jpad.2021.23
   PubMed Web of Science ®Google Scholar
• Ayre K, Krishnamoorthy G. 3.1 How the brain develops. In: Trauma Informed Behaviour Support: A Practical Guide to Developing Resilient Learners. University of Southern Queensland; 2020.
   Google Scholar
• Ismail Z, Black SE, Camicioli R, et al. Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Alzheimers Dement. 2020;16(8):1182–1195. doi:10.1002/alz.12105
   PubMed Web of Science ®Google Scholar
• Ashrafian H, Zadeh EH, Khan RH. Review on Alzheimer’s disease: inhibition of amyloid beta and tau tangle formation. Int J Biol Macromol. 2021;167:382–394. doi:10.1016/j.ijbiomac.2020.11.192
   PubMed Web of Science ®Google Scholar
• Vogel JW, Iturria-Medina Y, Strandberg OT, et al. Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease. Nat Commun. 2020;11(1):2612. doi:10.1038/s41467-020-15701-2
   PubMed Web of Science ®Google Scholar
• Volicer L. Physiological and pathological functions of beta-amyloid in the brain and Alzheimer’s disease: a review. Chin J Physiol. 2020;63(3):95. doi:10.4103/CJP.CJP_10_20
   PubMed Web of Science ®Google Scholar
• Karran E, De Strooper B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov. 2022;21(4):306–318. doi:10.1038/s41573-022-00391-w
   PubMed Web of Science ®Google Scholar
• Hampel H, Vassar R, De Strooper B, et al. The β-secretase BACE1 in Alzheimer’s disease. Biol Psychiatry. 2021;89(8):745–756. doi:10.1016/j.biopsych.2020.02.001
   PubMed Web of Science ®Google Scholar
• Babusikova E, Dobrota D, Turner AJ, et al. Effect of global brain ischemia on amyloid precursor protein metabolism and expression of amyloid-degrading enzymes in rat cortex: role in pathogenesis of Alzheimer’s disease. Biochemistry. 2021;86(6):680–692. doi:10.1134/S0006297921060067
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang Q, Chen S, et al. Functions of amyloid precursor protein in metabolic diseases. Metabolism. 2021;115:154454. doi:10.1016/j.metabol.2020.154454
   PubMed Web of Science ®Google Scholar
• Leong YQ, Ng KY, Chye SM, et al. Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death. Metab Brain Dis. 2020;35(1):11–30. doi:10.1007/s11011-019-00516-y
   PubMed Web of Science ®Google Scholar
• Flores J, Noël A, Fillion M-L, et al. Therapeutic potential of Nlrp1 inflammasome, Caspase-1, or Caspase-6 against Alzheimer disease cognitive impairment. Cell Death Differ. 2022;29(3):657–669. doi:10.1038/s41418-021-00881-1
   PubMed Web of Science ®Google Scholar
• Sharma VK, Singh TG, Singh S, et al. Apoptotic pathways and Alzheimer’s disease: probing therapeutic potential. Neurochem Res. 2021;46(12):3103–3122. doi:10.1007/s11064-021-03418-7
   PubMed Web of Science ®Google Scholar
• Seubert P, Oltersdorf T, Lee MG, et al. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature. 1993;361(6409):260–263. doi:10.1038/361260a0
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Rockenstein E, Crews L, et al. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer’s and Parkinson’s diseases. Neuromolecular Med. 2003;4:21–35. doi:10.1385/NMM:4:1-2:21
   PubMed Web of Science ®Google Scholar
• Peng C, Trojanowski JQ, Lee VM-Y. Protein transmission in neurodegenerative disease. Nat Rev Neurol. 2020;16(4):199–212. doi:10.1038/s41582-020-0333-7
   PubMed Web of Science ®Google Scholar
• Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(3):a006312. doi:10.1101/cshperspect.a006312
   PubMed Web of Science ®Google Scholar
• Bu G. Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci. 2009;10(5):333–344. doi:10.1038/nrn2620
   PubMed Web of Science ®Google Scholar
• Zhang X, Qu -Y-Y, Liu L, et al. Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation. Cell Rep. 2021;37(2):109821. doi:10.1016/j.celrep.2021.109821
   PubMed Web of Science ®Google Scholar
• Johnstone M, Gearing AJ, Miller KM. A central role for astrocytes in the inflammatory response to β-amyloid; chemokines, cytokines and reactive oxygen species are produced. J Neuroimmunol. 1999;93(1–2):182–193. doi:10.1016/S0165-5728(98)00226-4
   PubMed Web of Science ®Google Scholar
• Ramesh G, MacLean AG, Philipp MT. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013;2013:1–20. doi:10.1155/2013/480739
   Web of Science ®Google Scholar
• Alberghina L, Colangelo AM. The modular systems biology approach to investigate the control of apoptosis in Alzheimer’s disease neurodegeneration. BMC Neurosci. 2006;7:1–26. doi:10.1186/1471-2202-7-S1-S2
   PubMed Web of Science ®Google Scholar
• Gunn AP, Wong BX, Johanssen T, et al. Amyloid-β peptide Aβ3pE-42 induces lipid peroxidation, membrane permeabilization, and calcium influx in neurons. J Biol Chem. 2016;291(12):6134–6145. doi:10.1074/jbc.M115.655183
   PubMed Web of Science ®Google Scholar
• Gan X, Huang S, Wu L, et al. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer’s disease cybrid cell. Biochim Biophys Acta. 2014;1842(2):220–231. doi:10.1016/j.bbadis.2013.11.009
   PubMed Web of Science ®Google Scholar
• Zeng Q, Bie B, Guo Q, et al. Hyperpolarized Xe NMR signal advancement by metal-organic framework entrapment in aqueous solution. Proce Natl Acad Sci. 2020;117(30):17558–17563. doi:10.1073/pnas.2004121117
   PubMed Web of Science ®Google Scholar
• Hooper C, Killick R, Lovestone S. The GSK3 hypothesis of Alzheimer’s disease. J Neurochem. 2008;104(6):1433–1439. doi:10.1111/j.1471-4159.2007.05194.x
   PubMed Web of Science ®Google Scholar
• Town T, Zolton J, Shaffner R, et al. p35/Cdk5 pathway mediates soluble amyloid‐β peptide‐induced tau phosphorylation in vitro. J Neurosci Res. 2002;69(3):362–372. doi:10.1002/jnr.10299
   PubMed Web of Science ®Google Scholar
• Das A, Dikshit M, Nath C. Role of molecular isoforms of acetylcholinesterase in learning and memory functions. Pharmacol Biochem Behav. 2005;81(1):89–99. doi:10.1016/j.pbb.2005.02.006
   PubMed Web of Science ®Google Scholar
• Tiwari P, Dwivedi S, Singh MP, et al. Basic and modern concepts on cholinergic receptor: a review. Asian Pacific J Trop Dis. 2013;3(5):413–420. doi:10.1016/S2222-1808(13)60094-8
   Google Scholar
• Hampel H, Mesulam -M-M, Cuello AC, et al. Khachaturian. Brain: a Journal of Neurology. 2018;141(7):1917–1933. doi:10.1093/brain/awy132
   PubMed Web of Science ®Google Scholar
• Plant C, Teipel SJ, Oswald A, et al. Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer’s disease. Neuroimage. 2010;50(1):162–174. doi:10.1016/j.neuroimage.2009.11.046
   PubMed Web of Science ®Google Scholar
• Rami L, Sala-Llonch R, Solé-Padullés C, et al. Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer’s disease. J Alzheimer’s Dis. 2012;31(3):517–526. doi:10.3233/JAD-2012-120223
   PubMed Web of Science ®Google Scholar
• Rodriguez RD, Grinberg LT. Argyrophilic grain disease: an underestimated tauopathy. Dement Neuropsychol. 2015;9(1):2–8. doi:10.1590/S1980-57642015DN91000002
   PubMedGoogle Scholar
• Wang F, Wang H, Zhou X, et al. A driving fatigue feature detection method based on multifractal theory. IEEE Sens J. 2022;22(19):19046–19059. doi:10.1109/JSEN.2022.3201015
   Web of Science ®Google Scholar
• Abner EL, Neltner JH, Jicha GA, et al. Diffuse amyloid-β plaques, neurofibrillary tangles, and the impact of APOE in elderly persons’ brains lacking neuritic amyloid plaques. J Alzheimer’s Dis. 2018;64(4):1307–1324. doi:10.3233/JAD-180514
   PubMed Web of Science ®Google Scholar
• Ferrer I, Santpere G, van Leeuwen FW. Argyrophilic grain disease. Brain. 2008;131(6):1416–1432. doi:10.1093/brain/awm305
   PubMedGoogle Scholar
• Togo T, Isojima D, Akatsu H, et al. Clinical features of argyrophilic grain disease: a retrospective survey of cases with neuropsychiatric symptoms. Am J Geriatric Psychiatry. 2005;13(12):1083–1091. doi:10.1097/00019442-200512000-00008
   PubMed Web of Science ®Google Scholar
• Zhang K, Yang Y, Ge H, et al. Neurogenesis and Proliferation of neural stem/progenitor cells conferred by artesunate via FOXO3a/p27Kip1 Axis in mouse stroke model. Mol Neurobiol. 2022;59(8):4718–4729. doi:10.1007/s12035-021-02710-5
   PubMed Web of Science ®Google Scholar
• Petersen RC, Parisi JE, Dickson DW, et al. Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol. 2006;63(5):665–672. doi:10.1001/archneur.63.5.665
   PubMedGoogle Scholar
• Saito Y, Murayama S. Neuropathology of mild cognitive impairment. Neuropathology. 2007;27(6):578–584. doi:10.1111/j.1440-1789.2007.00806.x
   PubMed Web of Science ®Google Scholar
• Brouwers S, Sudano I, Kokubo Y, et al. Arterial hypertension. Lancet. 2021;398(10296):249–261. doi:10.1016/S0140-6736(21)00221-X
   PubMed Web of Science ®Google Scholar
• Twagirumukiza M, De Bacquer D, Kips JG, et al. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. J Hypertens. 2011;29(7):1243–1252. doi:10.1097/HJH.0b013e328346995d
   PubMed Web of Science ®Google Scholar
• Snarska K, Chorąży M, Szczepański M, et al. Quality of life of patients with arterial hypertension. Medicina. 2020;56(9):459. doi:10.3390/medicina56090459
   PubMedGoogle Scholar
• Valenzuela PL, Carrera-Bastos P, Gálvez BG, et al. Lifestyle interventions for the prevention and treatment of hypertension. Nat Rev Cardiol. 2021;18(4):251–275. doi:10.1038/s41569-020-00437-9
   PubMed Web of Science ®Google Scholar
• Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients. Heart. 2019;105(2):98–105. doi:10.1136/heartjnl-2018-313599
   PubMed Web of Science ®Google Scholar
• Zeng Z, Chen J, Xiao C, Chen W. A global view on prevalence of hypertension and human develop index. Ann Global Health. 2020;86(1):67.
   PubMed Web of Science ®Google Scholar
• Schutte AE, Srinivasapura Venkateshmurthy N, Mohan S, et al. Hypertension in low-and middle-income countries. Circ Res. 2021;128(7):808–826. doi:10.1161/CIRCRESAHA.120.318729
   PubMed Web of Science ®Google Scholar
• Macquart de Terline D, Kane A, Kramoh KE, et al. Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income Sub-Saharan countries. PLoS One. 2019;14(7):e0219266. doi:10.1371/journal.pone.0219266
   PubMed Web of Science ®Google Scholar
• Uchmanowicz I, Markiewicz K, Uchmanowicz B, et al. The relationship between sleep disturbances and quality of life in elderly patients with hypertension. Clin Interv Aging. 2019;Volume 14:155–165. doi:10.2147/CIA.S188499
   Web of Science ®Google Scholar
• Liu P, Shi J, Wang Z-A. Pattern formation of the attraction-repulsion Keller-Segel system. Discrete Continuous Dyn Syst Ser B. 2013;18(10):2597. doi:10.3934/dcdsb.2013.18.2597
   Web of Science ®Google Scholar
• Yamazaki D, Hitomi H, Nishiyama A. Hypertension with diabetes mellitus complications. Hyperten Res. 2018;41(3):147–156. doi:10.1038/s41440-017-0008-y
   PubMed Web of Science ®Google Scholar
• Vidal-Petiot E, Greenlaw N, Ford I, et al. Relationships between components of blood pressure and cardiovascular events in patients with stable coronary artery disease and hypertension. Hypertension. 2018;71(1):168–176. doi:10.1161/HYPERTENSIONAHA.117.10204
   PubMed Web of Science ®Google Scholar
• Jin H-Y, Wang Z-A. Global stabilization of the full attraction-repulsion Keller-Segel system. arXiv preprint arXiv:1905 05990; 2019.
   Google Scholar
• Jamerson KA, Nasser SA, Ferdinand KC. Cardiovascular disease in minorities: unique considerations: hypertension in African and Hispanic Americans. Cardiovascular Disease in Racial and Ethnic Minority Populations. Springer. 2021:159–166.
   Google Scholar
• Costa SDM, Lima CDA, Nobre ALCSD, et al. Hypertension bearers with high risk/big risk of cardiovascular diseases and socioeconomic and health indicators. Revista da Associação Médica Brasileira. 2018;64(p):601–610. doi:10.1590/1806-9282.64.07.601
   PubMedGoogle Scholar
• Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–237. doi:10.1038/s41581-019-0244-2
   PubMed Web of Science ®Google Scholar
• Mollan SP, Aguiar M, Evison F, et al. The expanding burden of idiopathic intracranial hypertension. Eye. 2019;33(3):478–485. doi:10.1038/s41433-018-0238-5
   PubMed Web of Science ®Google Scholar
• Jin H-Y, Wang Z-A. Boundedness, blowup and critical mass phenomenon in competing chemotaxis. J Differ Equ. 2016;260(1):162–196. doi:10.1016/j.jde.2015.08.040
   Web of Science ®Google Scholar
• Kirkland EB, Heincelman M, Bishu KG, et al. Trends in healthcare expenditures among US adults with hypertension: national estimates, 2003–2014. J Am Heart Assoc. 2018;7(11):e008731. doi:10.1161/JAHA.118.008731
   PubMed Web of Science ®Google Scholar
• Jin HY, Wang ZA. Asymptotic dynamics of the one‐dimensional attraction–repulsion Keller–Segel model. Math Methods Appl Sci. 2015;38(3):444–457. doi:10.1002/mma.3080
   Web of Science ®Google Scholar
• Foy AJ, Mandrola JM. Heavy heart: the economic burden of heart disease in the United States Now and in the future. Prim Care. 2018;45(1):17–24. doi:10.1016/j.pop.2017.11.002
   PubMed Web of Science ®Google Scholar
• Wiinberg N, Høegholm A, Christensen HR, et al. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens. 1995;8(10):978–986. doi:10.1016/0895-7061(95)00216-2
   PubMed Web of Science ®Google Scholar
• Jennings JR, Zanstra Y. Is the brain the essential in hypertension? Neuroimage. 2009;47(3):914–921. doi:10.1016/j.neuroimage.2009.04.072
   PubMed Web of Science ®Google Scholar
• Korner PI. Essential Hypertension and Its Causes: Neural and Non-Neural Mechanisms. Oxford University Press; 2007.
   Google Scholar
• Harvey A, Montezano AC, Lopes RA, et al. Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications. Can J Cardiol. 2016;32(5):659–668. doi:10.1016/j.cjca.2016.02.070
   PubMed Web of Science ®Google Scholar
• Meissner A. Hypertension and the brain: a risk factor for more than heart disease. Cerebrovasc Sis. 2016;42(3–4):255–262. doi:10.1159/000446082
   PubMed Web of Science ®Google Scholar
• Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar diameter and risk for hypertension. Ann Intern Med. 2004;140(4):248–255. doi:10.7326/0003-4819-140-4-200402170-00006
   PubMed Web of Science ®Google Scholar
• Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. stroke. 2011;42(9):2672–2713. doi:10.1161/STR.0b013e3182299496
   PubMed Web of Science ®Google Scholar
• Petrou P, Gothelf Y, Argov Z, et al. Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of Phase 1/2 and 2a clinical trials. JAMA Neurol. 2016;73(3):337–344. doi:10.1001/jamaneurol.2015.4321
   PubMed Web of Science ®Google Scholar
• Shang X, Hill E, Zhu Z, et al. The association of age at diagnosis of hypertension with brain structure and incident dementia in the UK Biobank. Hypertension. 2021;78(5):1463–1474. doi:10.1161/HYPERTENSIONAHA.121.17608
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Toth P, Tarantini S, et al. Hypertension-induced cognitive impairment: from pathophysiology to public health. Nat Rev Nephrol. 2021;17(10):639–654. doi:10.1038/s41581-021-00430-6
   PubMed Web of Science ®Google Scholar
• Aam S, Gynnild MN., Munthe-Kaas R, et al. The impact of vascular risk factors on post-stroke cognitive impairment: the Nor-COAST study. Front Neurol. 2021;1083. doi:10.3389/fneur.2021.678794
   Google Scholar
• Sierra C. Hypertension and the risk of dementia. Front Cardiovasc Med. 2020;7:5. doi:10.3389/fcvm.2020.00005
   PubMed Web of Science ®Google Scholar
• Abell JG, Kivimäki M, Dugravot A, et al. Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension. Eur Heart J. 2018;39(33):3119–3125. doi:10.1093/eurheartj/ehy288
   PubMed Web of Science ®Google Scholar
• Gottesman RF, Seshadri S. Risk factors, lifestyle behaviors, and vascular brain health. Stroke. 2022;53(2):394–403. doi:10.1161/STROKEAHA.121.032610
   PubMed Web of Science ®Google Scholar
• Li G, Rhew IC, Shofer JB, et al. Age‐varying association between blood pressure and risk of dementia in those aged 65 and older: a community‐based prospective cohort study. J Am Geriatr Soc. 2007;55(8):1161–1167. doi:10.1111/j.1532-5415.2007.01233.x
   PubMed Web of Science ®Google Scholar
• Wetterberg H, Najar J, Rydén L, et al. Blood pressure at the age of 70 as a predictor of incident dementia: a 15‐year longitudinal study: epidemiology/Risk and protective factors in MCI and dementia. Alzheimers Dement. 2020;16:e045841. doi:10.1002/alz.045841
   Google Scholar
• Rutherford BR, Brewster K, Golub JS, et al. Sensation and psychiatry: linking age-related hearing loss to late-life depression and cognitive decline. Am J Psychiatry. 2018;175(3):215–224. doi:10.1176/appi.ajp.2017.17040423
   PubMed Web of Science ®Google Scholar
• Thorin-Trescases N, de Montgolfier O, Pinçon A, et al. Impact of pulse pressure on cerebrovascular events leading to age-related cognitive decline. Am J Physiol. 2018;314(6):H1214–H1224. doi:10.1152/ajpheart.00637.2017
   Google Scholar
• Johnson EE, Alexander C, Lee GJ, et al. Examination of race and gender differences in predictors of neuropsychological decline and development of Alzheimer’s disease. Clin Neuropsychol. 2022;36(2):327–352. doi:10.1080/13854046.2021.1940299
   PubMed Web of Science ®Google Scholar
• Joo SH, Yun SH, Kang DW, et al. Body mass index in mild cognitive impairment according to age, sex, cognitive intervention, and hypertension and risk of progression to Alzheimer’s disease. Frontiers in Psychiatry. 2018;9:142. doi:10.3389/fpsyt.2018.00142
   PubMed Web of Science ®Google Scholar
• Gilsanz P, Mayeda ER, Glymour MM, et al. Female sex, early-onset hypertension, and risk of dementia. Neurology. 2017;89(18):1886–1893. doi:10.1212/WNL.0000000000004602
   PubMed Web of Science ®Google Scholar
• Forcaia G, Formicola B, Terribile G, et al. Multifunctional liposomes modulate purinergic receptor-induced calcium wave in cerebral microvascular endothelial cells and astrocytes: new insights for Alzheimer’s disease. Mol Neurobiol. 2021;58(6):2824–2835. doi:10.1007/s12035-021-02299-9
   PubMed Web of Science ®Google Scholar
• Myers DR, Lam WA. Vascularized microfluidics and their untapped potential for discovery in diseases of the microvasculature. Annu Rev Biomed Eng. 2021;23(1):407–432. doi:10.1146/annurev-bioeng-091520-025358
   PubMedGoogle Scholar
• Uddin MS, Rahman MA, Kabir MT, et al. Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of AlzheimerAlzheimer’s disease. Iubmb Life. 2020;72(9):1843–1855. doi:10.1002/iub.2324
   PubMed Web of Science ®Google Scholar
• Ramos-Cejudo J, Wisniewski T, Marmar C, et al. Traumatic brain injury and Alzheimer’s disease: the cerebrovascular link. EBioMedicine. 2018;28:21–30. doi:10.1016/j.ebiom.2018.01.021
   PubMed Web of Science ®Google Scholar
• Cheng Y-W, Chiu MJ, Chen YF, Cheng TW, Lai YM, Chen TF. The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer’s disease. Alzheimer’s Res Ther. 2020;12(1):1–10.
   Web of Science ®Google Scholar
• Tariq S, Barber PA. Dementia risk and prevention by targeting modifiable vascular risk factors. J Neurochem. 2018;144(5):565–581. doi:10.1111/jnc.14132
   PubMed Web of Science ®Google Scholar
• He J-T, Zhao X, Xu L, et al. Vascular risk factors and Alzheimer’s disease: blood-brain barrier disruption, metabolic syndromes, and molecular links. J Alzheimer’s Dis. 2020;73(1):39–58. doi:10.3233/JAD-190764
   PubMed Web of Science ®Google Scholar
• Mosconi L, Walters M, Sterling J, et al. Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer’s disease: a cross-sectional study of middle-aged adults from the broader New York City area. BMJ open. 2018;8(3):e019362. doi:10.1136/bmjopen-2017-019362
   PubMed Web of Science ®Google Scholar
• Cheng G, He S, He Q, et al. Trajectory patterns of blood pressure change up to six years and the risk of dementia: a nationwide cohort study. Aging. 2021;13(13):17380. doi:10.18632/aging.203228
   PubMedGoogle Scholar
• Tarantini S, Tucsek Z, Valcarcel-Ares MN, et al. Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging. Age. 2016;38(4):273–289. doi:10.1007/s11357-016-9931-0
   PubMedGoogle Scholar
• Bowman GL, Dayon L, Kirkland R, et al. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults. Alzheimers Dement. 2018;14(12):1640–1650. doi:10.1016/j.jalz.2018.06.2857
   PubMed Web of Science ®Google Scholar
• Liao Y, Fan Y, He Q, et al. Exogenous H2S ameliorates high salt-induced hypertension by alleviating oxidative stress and inflammation in the paraventricular nucleus in Dahl S rats. Cardiovasc Toxicol. 2022;22(5):477–491. doi:10.1007/s12012-022-09729-7
   PubMed Web of Science ®Google Scholar
• Jiang E, Chapp AD, Fan Y, et al. Expression of proinflammatory cytokines is upregulated in the hypothalamic paraventricular nucleus of dahl salt-sensitive hypertensive rats. Front Physiol. 2018;9:104. doi:10.3389/fphys.2018.00104
   PubMed Web of Science ®Google Scholar
• Fang X, Crumpler RF, Thomas KN, et al. Contribution of cerebral microvascular mechanisms to age-related cognitive impairment and dementia. Physiol Int. 2022;109(1):20–30. doi:10.1556/2060.2022.00020
   Web of Science ®Google Scholar
• Park L, Zhou P, Koizumi K, et al. Brain and circulating levels of Aβ1–40 differentially contribute to vasomotor dysfunction in the mouse brain. Stroke. 2013;44(1):198–204. doi:10.1161/STROKEAHA.112.670976
   PubMed Web of Science ®Google Scholar
• Park L, Koizumi K, El Jamal S, et al. Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy. Stroke. 2014;45(6):1815–1821. doi:10.1161/STROKEAHA.114.005179
   PubMed Web of Science ®Google Scholar
• Bertsch M, Franchi B, Meacci L, et al. The amyloid cascade hypothesis and Alzheimer’s disease: a mathematical model. Eur J Appl Math. 2021;32(5):749–768. doi:10.1017/S0956792520000339
   Web of Science ®Google Scholar
• Tolar M, Abushakra S, Sabbagh M. The path forward in Alzheimer’s disease therapeutics: reevaluating the amyloid cascade hypothesis. Alzheimers Dement. 2019. doi:10.1016/j.jalz.2019.09.075
   Web of Science ®Google Scholar
• De La Torre J, Mecocci P. The vascular hypothesis of Alzheimer’s disease: a key to preclinical prediction of dementia using neuroimaging. J Alzheimer’s Dis. 2018;63(1):35–52. doi:10.3233/JAD-180004
   PubMed Web of Science ®Google Scholar
• Stakos DA, Stamatelopoulos K, Bampatsias D, et al. The Alzheimer’s disease amyloid-beta hypothesis in cardiovascular aging and disease: JACC focus seminar. J Am Coll Cardiol. 2020;75(8):952–967. doi:10.1016/j.jacc.2019.12.033
   PubMed Web of Science ®Google Scholar
• Woods C, Marques-Lopes J, Contoreggi NH, et al. Tumor necrosis factor α receptor type 1 activation in the hypothalamic paraventricular nucleus contributes to glutamate signaling and angiotensin II-dependent hypertension. J Neurosci. 2021;41(6):1349–1362. doi:10.1523/JNEUROSCI.2360-19.2020
   PubMed Web of Science ®Google Scholar
• Oscanoa TJ, Amado J, Vidal X, Romero-Ortuno R. Angiotensin-receptor blockers and the risk of Alzheimer s disease: a meta-analysis. Curr Rev. 2021;16(1):73–78.
   Google Scholar
• Cosarderelioglu C, George CJ, Xue Q-L, et al. Angiotensin receptor blockers upregulate angiotensin type 4 receptor in brains of cognitively intact individuals. Innovat Aging. 2021;5(Supplement_1):634. doi:10.1093/geroni/igab046.2411
   Google Scholar
• Giardini A, Piva T, Picchio FM, et al. Impact of transverse aortic arch hypoplasia after surgical repair of aortic coarctation: an exercise echo and magnetic resonance imaging study. Int J Cardiol. 2007;119(1):21–27. doi:10.1016/j.ijcard.2006.07.036
   PubMed Web of Science ®Google Scholar
• Tran S, Kuruppu S, Rajapakse NW. Chronic renin-angiotensin System Activation induced neuroinflammation: common mechanisms underlying hypertension and dementia? J Alzheimer’s Dis. 2022;85(3):943–955. doi:10.3233/JAD-215231
   PubMed Web of Science ®Google Scholar
• Zhang D, Wang YG, Liu CY, et al. Aminoguanidine ameliorates ovariectomy‑induced neuronal deficits in rats by inhibiting AGE‑mediated Aβ production. Acta Neurobiol Exp. 2021;81(1):10–20. doi:10.21307/ane-2021-002
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang R, Tao C, et al. Blood-brain barrier disruption and perivascular beta-amyloid accumulation in the brain of aged rats with spontaneous hypertension: evaluation with dynamic contrast-enhanced magnetic resonance imaging. Korean J Radiol. 2018;19(3):498–507. doi:10.3348/kjr.2018.19.3.498
   PubMed Web of Science ®Google Scholar
• Csiszar A, Tucsek Z, Toth P, et al. Synergistic effects of hypertension and aging on cognitive function and hippocampal expression of genes involved in β-amyloid generation and Alzheimer’s disease. Am J Physiol. 2013;305(8):H1120–H1130. doi:10.1152/ajpheart.00288.2013
   Google Scholar
• van der Kant R, Goldstein LS, Ossenkoppele R. Amyloid-β-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci. 2020;21(1):21–35. doi:10.1038/s41583-019-0240-3
   PubMed Web of Science ®Google Scholar
• Hu H, Meng L, Bi Y-L, et al. Tau pathologies mediate the association of blood pressure with cognitive impairment in adults without dementia: the CABLE study. Alzheimers Dement. 2022;18(1):53–64. doi:10.1002/alz.12377
   PubMed Web of Science ®Google Scholar
• Laing KK, Simoes S, Baena-Caldas GP, et al. Cerebrovascular disease promotes tau pathology in Alzheimer’s disease. Brain commun. 2020;2(2):fcaa132. doi:10.1093/braincomms/fcaa132
   PubMedGoogle Scholar
• Chiang GC, Mao X, Kang G, et al. Relationships among cortical glutathione levels, brain amyloidosis, and memory in healthy older adults investigated in vivo with 1 H-MRS and Pittsburgh compound-B PET. Am J Neuroradiol. 2017;38(6):1130–1137. doi:10.3174/ajnr.A5143
   PubMed Web of Science ®Google Scholar
• Raskin J, Cummings J, Hardy J, et al. Neurobiology of Alzheimer’s disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions. Curr Alzheimer Res. 2015;12(8):712–722. doi:10.2174/1567205012666150701103107
   PubMed Web of Science ®Google Scholar
• Schreiber S, Drukarch B, Garz C, et al. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats. J Alzheimer’s Dis. 2014;42(s3):S205–S215. doi:10.3233/JAD-132618
   PubMedGoogle Scholar
• Kurata T, Lukic V, Kozuki M, et al. Telmisartan reduces progressive accumulation of cellular amyloid beta and phosphorylated tau with inflammatory responses in aged spontaneously hypertensive stroke resistant rat. J Stroke Cerebrovasc Dis. 2014;23(10):2580–2590. doi:10.1016/j.jstrokecerebrovasdis.2014.05.023
   PubMed Web of Science ®Google Scholar
• Castillo-Carranza DL, Nilson AN, Van Skike CE, et al. Cerebral microvascular accumulation of tau oligomers in Alzheimer’s disease and related tauopathies. Aging Dis. 2017;8(3):257. doi:10.14336/AD.2017.0112
   PubMed Web of Science ®Google Scholar
• Iadecola C, Gottesman RF. Cerebrovascular alterations in Alzheimer disease: incidental or pathogenic? Circ Res. 2018;123(4):406–408. doi:10.1161/CIRCRESAHA.118.313400
   PubMed Web of Science ®Google Scholar
• Watase H, Sun J, Hippe DS, et al. Carotid artery remodeling is segment specific: an in vivo study by vessel wall magnetic resonance imaging. Arterioscler Thromb Vasc Biol. 2018;38(4):927–934. doi:10.1161/ATVBAHA.117.310296
   PubMed Web of Science ®Google Scholar
• Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308(9):875–881. doi:10.1001/2012.jama.10503
   PubMed Web of Science ®Google Scholar
• Jefferson AL, Cambronero FE, Liu D, et al. Higher aortic stiffness is related to lower cerebral blood flow and preserved cerebrovascular reactivity in older adults. Circulation. 2018;138(18):1951–1962. doi:10.1161/CIRCULATIONAHA.118.032410
   PubMed Web of Science ®Google Scholar
• DuBose LE, Boles Ponto LL, Moser DJ, et al. Higher aortic stiffness is associated with lower global cerebrovascular reserve among older humans. Hypertension. 2018;72(2):476–482. doi:10.1161/HYPERTENSIONAHA.118.11143
   PubMed Web of Science ®Google Scholar
• Schnerr RS, Jansen JFA, Uludag K, et al. Pulsatility of lenticulostriate arteries assessed by 7 Tesla flow MRI—Measurement, reproducibility, and applicability to aging effect. Front Physiol. 2017;8:961. doi:10.3389/fphys.2017.00961
   PubMed Web of Science ®Google Scholar
• Jackson R, Bellamy M. Antihypertensive drugs. Contin Educ Anaesth Crit Care Pain. 2015;15(6):280–285.
   Google Scholar
• Brunström M, Carlberg B. Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(1):28–36. doi:10.1001/jamainternmed.2017.6015
   PubMed Web of Science ®Google Scholar
• Iadecola C, Yaffe K, Biller J, et al. Impact of hypertension on cognitive function: a scientific statement from the American Heart Association. Hypertension. 2016;68(6):e67–e94. doi:10.1161/HYP.0000000000000053
   PubMed Web of Science ®Google Scholar
• Williamson JD, Pajewski NM, Auchus AP, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321(6):553–561. doi:10.1001/jama.2018.21442
   PubMed Web of Science ®Google Scholar
• Hernandorena I, Duron E, Vidal J-S, et al. Treatment options and considerations for hypertensive patients to prevent dementia. Expert Opin Pharmacother. 2017;18(10):989–1000. doi:10.1080/14656566.2017.1333599
   PubMed Web of Science ®Google Scholar
• Li N-C, Lee A, Whitmer RA, et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ. 2010;340(1):b5465. doi:10.1136/bmj.b5465
   PubMedGoogle Scholar
• Khachaturian AS, Zandi PP, Lyketsos CG, et al. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006;63(5):686–692. doi:10.1001/archneur.63.5.noc60013
   PubMed Web of Science ®Google Scholar
• Vazirinejad R, Mirmotalebi M, Bageri M, et al. Age-related effect of antihypertensive treatment on cognitive performance: is it better preventing dementia in older age? Am J Alzheimer’s Dis Other Dement. 2019;34(7–8):486–491. doi:10.1177/1533317519859197
   PubMed Web of Science ®Google Scholar
• McGeer EG, McGeer PL. Clinically tested drugs for Alzheimer’s disease. Expert Opin Investig Drugs. 2003;12(7):1143–1151. doi:10.1517/13543784.12.7.1143
   PubMed Web of Science ®Google Scholar
• van Dalen JW, Moll van Charante EP, van Gool WA, et al. Discontinuation of antihypertensive medication, cognitive complaints, and incident dementia. J Am Med Dir Assoc. 2019;20(9):1091–1097. e3. doi:10.1016/j.jamda.2018.12.006
   PubMed Web of Science ®Google Scholar
• Desormais I, Amidou SA, Houehanou YC, et al. The prevalence, awareness, management and control of hypertension in men and women in Benin, West Africa: the TAHES study. BMC Cardiovasc Disord. 2019;19(1):1–12. doi:10.1186/s12872-019-01273-7
   PubMed Web of Science ®Google Scholar
• Gelaw S, Yenit MK, Nigatu SG, Moreira TMM. Self-care practice and associated factors among hypertensive patients in Debre Tabor Referral Hospital, Northwest Ethiopia, 2020. Int J Hypertens. 2021;2021:1–9. doi:10.1155/2021/3570050
   Web of Science ®Google Scholar
• Watts P, Rance S, McGowan V, et al. The long-term health and wellbeing impacts of Healthy New Towns (HNTs): protocol for a baseline and feasibility study of HNT demonstrator sites in England. Pilot Feasibil Stud. 2020;6(1):1–13. doi:10.1186/s40814-020-0550-2
   PubMedGoogle Scholar
• Cifkova R, Fodor G, Wohlfahrt P. Changes in hypertension prevalence, awareness, treatment, and control in high-, middle-, and low-income countries: an update. Curr Hypertens Rep. 2016;18(8):1–6. doi:10.1007/s11906-016-0669-y
   PubMed Web of Science ®Google Scholar
• Souza FJ, Santos AG, de Morais KA, et al. Análise do Perfi l dos Praticantes de Mountain Bike (MTB) da Cidade de Trindade (GO). Vita et Sanitas. 2016;10(1):22–37.
   Google Scholar
• Jorge C, Cetó M, Arias A, et al. level of understanding of Alzheimer disease among caregivers and the general population. Neurología. 2021;36(6):426–432. doi:10.1016/j.nrl.2018.03.004
   PubMed Web of Science ®Google Scholar
• Danta CC. Calcium channel blockers: a possible potential therapeutic strategy for the treatment of Alzheimer’s dementia patients with SARS-CoV-2 infection. ACS Chem Neurosci. 2020;11(15):2145–2148. doi:10.1021/acschemneuro.0c00391
   PubMed Web of Science ®Google Scholar
• Lebouvier T, Chen Y, Duriez P, et al. Antihypertensive agents in Alzheimer’s disease: beyond vascular protection. Expert Rev Neurother. 2020;20(2):175–187. doi:10.1080/14737175.2020.1708195
   PubMed Web of Science ®Google Scholar
• Schmukler E, Pinkas-Kramarski R. Autophagy induction in the treatment of Alzheimer’s disease. Drug Dev Res. 2020;81(2):184–193. doi:10.1002/ddr.21605
   PubMed Web of Science ®Google Scholar
• Gupta GL, Samant NP. Current druggable targets for therapeutic control of Alzheimer’s disease. Contemp Clin Trials. 2021;109:106549. doi:10.1016/j.cct.2021.106549
   PubMed Web of Science ®Google Scholar
• Ribeiro VT, de Souza LC, Simoes ESAC. Renin-angiotensin system and Alzheimer’s disease pathophysiology: from the potential interactions to therapeutic perspectives. Protein Pept Lett. 2020;27(6):484–511.
   PubMed Web of Science ®Google Scholar
• Chung MK, Karnik S, Saef J, et al. SARS-CoV-2 and ACE2: the biology and clinical data settling the ARB and ACEI controversy. EBioMedicine. 2020;58:102907. doi:10.1016/j.ebiom.2020.102907
   PubMed Web of Science ®Google Scholar
• Thomas J, Smith H, Smith CA, et al. The angiotensin-converting enzyme inhibitor lisinopril mitigates memory and motor deficits in a drosophila model of Alzheimer’s disease. Pathophysiology. 2021;28(2):307–319. doi:10.3390/pathophysiology28020020
   PubMedGoogle Scholar
• Ballard C, Aarsland D, Cummings J, et al. Drug repositioning and repurposing for Alzheimer disease. Nat Rev Neurol. 2020;16(12):661–673. doi:10.1038/s41582-020-0397-4
   PubMed Web of Science ®Google Scholar
• Barthold D, Joyce G, Diaz Brinton R, et al. Association of combination statin and antihypertensive therapy with reduced Alzheimer’s disease and related dementia risk. PLoS One. 2020;15(3):e0229541. doi:10.1371/journal.pone.0229541
   PubMed Web of Science ®Google Scholar
• Royea J, Lacalle-Aurioles M, Trigiani LJ, et al. AT2R’s (Angiotensin II Type 2 Receptor’s) role in cognitive and cerebrovascular deficits in a mouse model of Alzheimer disease. Hypertension. 2020;75(6):1464–1474. doi:10.1161/HYPERTENSIONAHA.119.14431
   PubMed Web of Science ®Google Scholar
• Royea J, Hamel E. Brain angiotensin II and angiotensin IV receptors as potential Alzheimer’s disease therapeutic targets. Geroscience. 2020;42(5):1237–1256. doi:10.1007/s11357-020-00231-y
   PubMed Web of Science ®Google Scholar
• Evans AK, Ardestani PM, Yi B, et al. Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer’s disease. Neurobiol Dis. 2020;146:105089. doi:10.1016/j.nbd.2020.105089
   PubMed Web of Science ®Google Scholar
• Yiannopoulou KG, Papageorgiou SG. Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis. 2020;12:1179573520907397. doi:10.1177/1179573520907397
   Web of Science ®Google Scholar